Population Pharmacokinetics and Exposure-Response Relationships of Astegolimab in Patients With Severe Asthma.
Saved in:
| Title: | Population Pharmacokinetics and Exposure-Response Relationships of Astegolimab in Patients With Severe Asthma. |
|---|---|
| Authors: | Kotani N; Genentech Inc., South San Francisco, California, USA.; Chugai Pharmaceutical Co. Ltd., Tokyo, Japan., Dolton M; Genentech Inc., South San Francisco, California, USA., Svensson RJ; Pharmetheus, Uppsala, Sweden., Ribbing J; Pharmetheus, Uppsala, Sweden., Friberg LE; Pharmetheus, Uppsala, Sweden.; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Vadhavkar S; Genentech Inc., South San Francisco, California, USA., Cheung D; Genentech Inc., South San Francisco, California, USA., Staton T; Genentech Inc., South San Francisco, California, USA., Sperinde G; Genentech Inc., South San Francisco, California, USA., Jin J; Genentech Inc., South San Francisco, California, USA., Putnam WS; Genentech Inc., South San Francisco, California, USA., Quartino A; Genentech Inc., South San Francisco, California, USA. |
| Source: | Journal of clinical pharmacology [J Clin Pharmacol] 2022 Jul; Vol. 62 (7), pp. 905-917. Date of Electronic Publication: 2022 Feb 09. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
